Biblio Discovery — Demo Discovery Service

6 results for "Bruno Raynard"

Showing 1–6 · 0.41 seconds · RSS

  1. Journal Article

    Nutrition, Ethics and Cancer, “To name things wrongly is to add to the misfortune of the world”

    Diana Cardenas; Bruno Raynard; François Blot

    Clinical Nutrition Open Science, Vol. 48 · 2023 · English · DOAJ Scopus

    Summary: Medical nutrition therapy is a full-fledged treatment such as antibiotics, antidiabetics or mechanical ventilation. Like any medical procedure, evidence-based medical nutrition therapy (from its indication and introduction, to the eventual interruption thereof) goes along with ethical…

  2. Journal Article

    Psoas muscle index is not representative of skeletal muscle index for evaluating cancer sarcopenia

    Frédéric Pigneur; Mario Di Palma; Bruno Raynard et al.

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 14 No. 4 · 2023 · English · DOAJ Scopus

    Abstract Background A common method for diagnosing sarcopenia involves estimating the muscle mass by computed tomography (CT) via measurements of the cross‐sectional muscle area (CSMA) of all muscles at the third lumbar vertebra (L3) level. Recently, single‐muscle measurements of the psoas major…

  3. Journal Article

    Is sarcopenia a missed factor in the management of patients with metastatic breast cancer?

    Elise Deluche; Denis Lachatre; Mario Di Palma et al.

    Breast, Vol. 61 · 2022 · English · DOAJ Scopus

    Background: Sarcopenia has emerged as an important parameter to predict outcomes and treatment toxicity. However, limited data are available to assess sarcopenia prevalence in metastatic breast cancer and to evaluate its management. Methods: The SCAN study was a cross-sectional multicenter French…

  4. Journal Article

    Weight and skeletal muscle loss with cabozantinib in metastatic renal cell carcinoma

    Emeline Colomba; Carolina Alves Costa Silva; Gwénaël Le Teuff et al.

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 13 No. 5 · 2022 · English · DOAJ Scopus

    Abstract Background Cabozantinib, a standard of care metastatic renal cell carcinoma (mRCC), may be associated with weight and muscle loss. These effects of new generation VEGFR tyrosine kinase inhibitor on muscle mass loss are poorly described. Methods All cabozantinib‐treated mRCC patients from…

  5. Journal Article

    Impact and consequences of intensive chemotherapy on intestinal barrier and microbiota in acute myeloid leukemia: the role of mucosal strengthening

    Thomas Hueso; Kenneth Ekpe; Camille Mayeur et al.

    Gut Microbes, Vol. 12 No. 1 · 2020 · English · DOAJ Scopus

    Induction chemotherapy (7 + 3 regimen) remains the gold standard for patients with acute myeloid leukemia (AML) but is responsible for gut damage leading to several complications such as bloodstream infection (BSI). We aimed to investigate the impact of induction chemotherapy on the intestinal…

  6. Journal Article

    A phase III randomized trial of weight loss to reduce cancer-related fatigue among overweight and obese breast cancer patients: MEDEA Study design

    Antonio Di Meglio; Elise Martin; Tracy E. Crane et al.

    Trials, Vol. 23 No. 1 · 2022 · English · DOAJ Scopus

    Abstract Background Elevated body mass index (BMI) represents a risk factor for cancer-related fatigue (CRF). Weight loss interventions are feasible and safe in cancer survivors, leading to improved cardio-metabolic and quality of life (QOL) outcomes and modulating inflammatory biomarkers…